Literature DB >> 17306253

Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density.

Shigeru Matsunaga1, Qiuhong Xie, Miyuki Kumano, Setsuko Niimi, Kyoko Sekizawa, Yoshikiyo Sakakibara, Shiro Komba, Sachiko Machida.   

Abstract

Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1) exists as a homodimer formed by an intermolecular disulfide bond. Although the dimer is the minimum structural unit of LOX-1 on cell membranes, LOX-1 can form larger noncovalent oligomeric complexes. But, the functional unit of LOX-1 is not known. We quantitatively analyzed the correlation between cyan fluorescent protein-tagged LOX-1 expression and the fluorescence-labeled ligand (DiD-AcLDL) binding ability on each cell. The results clearly indicate that there is a threshold level of expression that enables LOX-1 to bind ligand. Above this threshold level, the ability of LOX-1 to bind ligand was proportional to its level of expression. Using the membrane impermeable crosslinker BS(3), we detected oligomers (primarily hexamers) only on the cell lines that stably expressed LOX-1 above the threshold level. In contrast, little oligomer or ligand binding was detected in cell lines expressing LOX-1 below the threshold level. Moreover, oligomerization was independent of ligand binding. These results indicate that the functional unit of LOX-1 is an oligomer and that oligomerization of LOX-1 is dependent on the receptor density on the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306253     DOI: 10.1016/j.yexcr.2007.01.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  The LDL receptor-related protein can form homo-dimers in neuronal cells.

Authors:  Alexandra Makarova; Kathryn K Bercury; Kenneth W Adams; Daniel Joyner; Meihua Deng; Robert Spoelgen; Mirjam Koker; Dudley K Strickland; Bradley T Hyman
Journal:  Neurosci Lett       Date:  2008-06-28       Impact factor: 3.046

Review 2.  The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.

Authors:  Jianhui Xie
Journal:  Glycoconj J       Date:  2012-07-12       Impact factor: 2.916

3.  Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivo.

Authors:  Kousuke Ishino; Chika Wakita; Takahiro Shibata; Shinya Toyokuni; Sachiko Machida; Shun Matsuda; Tomonari Matsuda; Koji Uchida
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

4.  Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand.

Authors:  Takahiro Shibata; Yuuki Shimozu; Chika Wakita; Noriyuki Shibata; Makio Kobayashi; Sachiko Machida; Rina Kato; Hiroyuki Itabe; Xiaochun Zhu; Lawrence M Sayre; Koji Uchida
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

5.  Molecular mechanism of statin-mediated LOX-1 inhibition.

Authors:  Silvia Biocca; Federico Iacovelli; Sara Matarazzo; Giulia Vindigni; Francesco Oteri; Alessandro Desideri; Mattia Falconi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

7.  The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease.

Authors:  M W Twigg; K Freestone; S Homer-Vanniasinkam; S Ponnambalam
Journal:  Cardiol Res Pract       Date:  2012-02-19       Impact factor: 1.866

8.  Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.

Authors:  J Ramón Tejedor; Hagen Tilgner; Camilla Iannone; Roderic Guigó; Juan Valcárcel
Journal:  RNA       Date:  2015-04-22       Impact factor: 4.942

9.  Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.

Authors:  Torben Mentrup; Kosta Theodorou; Florencia Cabrera-Cabrera; Andreas O Helbig; Kathrin Happ; Marion Gijbels; Ann-Christine Gradtke; Björn Rabe; Akio Fukumori; Harald Steiner; Andreas Tholey; Regina Fluhrer; Marjo Donners; Bernd Schröder
Journal:  J Exp Med       Date:  2019-02-28       Impact factor: 14.307

10.  Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.

Authors:  Carmine Di Rienzo; Emanuela Jacchetti; Francesco Cardarelli; Ranieri Bizzarri; Fabio Beltram; Marco Cecchini
Journal:  Sci Rep       Date:  2013-01-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.